Abstract:Context - MicroRNAs (miRNAs) represent a class of small non-coding RNAs that regulate the gene expressions at the posttranscriptional level, subsequently control crucial physiological processes. Recent evidence demonstrates that some miRNAs have the functions similar to oncogene or tumor suppressors, It may play important roles in tumorigenesis MiRNA expression profiles may become useful biomarkers for cancer diagnostics, prognosis and prediction of response to treatment, and it could be a powerful tool for cancer prevention and therapeuticsObjective - To explore the global expression profile of miRNAs in non small cell lung cancer (NSCLC) and its potential relevance to clinicopathological characteristics and prognosis.Methods. - LNA microRNA microarrays were utilized to detect miRNA expression levels in eight surgically removed lung carcinoma tissues (La) and their corresponding normal lung tissues (NT) After initial microarray validation by quantitative real-time reverse transcription polymerase chain reaction assays (qRT-PCR), miR-21, miR-143 and miR-181a were selected for further study in another 47 paired LCTs and matched NTs by qRT-PCR using Taqman microRNA assay.Results. - Twenty-seven microRNAs were observed to be deregulated greater than two-fold in LCT compared with NT by microarray. Consistenting with the microarray, the expression level of miR-21 by qRT-PCR was significantly higher in tumor tissues than in adjacent normal tissues (P = 0026); while miR-143 (P = 0.000) and miR-181a (P= 0.000) were downregulated in LCT. Interestingly, among the 47 NSCLC cases, low level expression of miR-143 was significantly correlated with smoking status (P= 0026), high miR-21 expression (hazard ratio, 5993, 95% confidence interval, 2 518-14.264; P= 0.000) and low miR-181a expression (hazard ratio, 0.328, 95% confidence interval 0.142-0 756; P = 0.009) were associated with poor survival, independent of clinical covariates. including TNM staging, lymph note status.Conclusion. - Our data thus indicating the potential of miR-21, miR-143 and miR-181a as a novel diagnostic or prognostic biomarker for NSCLC. Besides, these data will guide further studies of specific microRNAs might become potential targets for therapeutic intervention. (C) 2010 Elsevier Masson SAS All rights reserved.

Expressions of Mirna-141 and Mirna-145 in Non-Small Cell Lung Cancer and Their Relation with Clinical Pathology

Deregulated Expression of Mir-21, Mir-143 and Mir-181A in Non Small Cell Lung Cancer is Related to Clinicopathologic Characteristics or Patient Prognosis

Expression and Clinical Significance of Mir-139-5p in Non-Small Cell Lung Cancer

Diagnostic Value of Serum Mir197 and Mir145 in Non-Small Cell Lung Cancer

Altered Mir-143 and Mir-150 Expressions in Peripheral Blood Mononuclear Cells for Diagnosis of Non-Small Cell Lung Cancer.

The expression of miR-145 in non-small cell lung cancer

Mir-145, Mir-21, Mir-10B Expression and Significance in Breast Cancer

Expression and Significance of Mir-143 and Mir-145 in Bladder Cancer

Expression and Clinical Significance of Mirna-145 and Mirna-218 in Laryngeal Cancer.

Down-regulation of Microrna-144-3p and Its Clinical Value in Non-Small Cell Lung Cancer: a Comprehensive Analysis Based on Microarray, Mirna-Sequencing, and Quantitative Real-Time PCR Data

Clinical value of miR-145-5p in NSCLC and potential molecular mechanism exploration: A retrospective study based on GEO, qRT-PCR, and TCGA data

Expressions of Mir-21 in Colon Cancer and Cancer-Adjacent Colorectal Tissues and Their Clinical Significances

Mirna Expression and Its Clinical Implications for the Prevention and Diagnosis of Non-Small-cell Lung Cancer

Low miR-145 expression level is associated with poor pathological differentiation and poor prognosis in non-small cell lung cancer.

[Expression of Mir-143 and Mir-145 and Their Functional Study in Gastric Carcinoma].

High Expression of Mir-21 and Mir-155 Predicts Recurrence and Unfavourable Survival in Non-Small Cell Lung Cancer

Expression of Mir-150 and Mir-3940-5p is Reduced in Non-Small Cell Lung Carcinoma and Correlates with Clinicopathological Features

Expression Level of Serum Mirna-22 and Its Clinical Significance in Patients with Lung Cancer

Downregulation of Serum Mir-101 is Associated with Worse Prognosis in Non-Small Cell Lung Cancer.

Expression of Mir-185 in Breast Cancer and Its Clinical Significance

The expression of miR-197 and miR-203 in serum of non-small cell lung cancer